Skip to main content
. 2013 May 2;14(8):993–1000. doi: 10.1002/cbic.201300115

Figure 1.

Figure 1

Prodrugs to correct dysfunctional mitochondria. The prodrug accummulates in all mitochondria because of its targeting group, but is only activated in mitochondria where ROS levels are high, with uncaging triggered by a ROS-sensitive group; the drug itself then interferes with the process that is giving rise to ROS, so that normal ROS levels are restored within the dysfunctional mitochondria.